BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8694531)

  • 1. Application of 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers.
    Kuliszkiewicz-Janus M; Janus W; Baczyński S
    Anticancer Res; 1996; 16(3B):1587-94. PubMed ID: 8694531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation in the course of hematological malignancies--follow-up study in blood serum by 31P MRS.
    Kuliszkiewicz-Janus M; Baczyński S; Jurczyk A
    Med Sci Monit; 2004 Aug; 10(8):CR485-92. PubMed ID: 15278000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-induced changes in 31P-MRS (magnetic resonance spectroscopy) spectra of sera from patients with acute leukemia.
    Kuliszkiewicz-Janus M; Baczyński S
    Biochim Biophys Acta; 1997 Feb; 1360(1):71-83. PubMed ID: 9061042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia.
    Kuliszkiewicz-Janus M; Tuz MA; Baczyński S
    Biochim Biophys Acta; 2005 Oct; 1737(1):11-5. PubMed ID: 16213190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human crystalline lens phospholipid analysis with age.
    Merchant TE; Lass JH; Meneses P; Greiner JV; Glonek T
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):549-55. PubMed ID: 2001928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 31P MRS analysis of the phospholipid composition of normal human peripheral blood mononuclear cells (PBMC).
    Kuliszkiewicz-Janus M; Tuz MA; Baczyński S; Prajs I; Jaźwiec B
    Cell Mol Biol Lett; 2005; 10(3):373-82. PubMed ID: 16217549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-associated changes in 31P MRS spectra of sera from patients with multiple myeloma.
    Kuliszkiewicz-Janus M; Baczyński S
    NMR Biomed; 1995 May; 8(3):127-32. PubMed ID: 8580000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The phospholipid spectrum of the blood serum in patients with chronic non-specific pulmonary diseases during rehabilitation treatment].
    Ivanov EM; Novgorodtseva TP; Endakova EA; Svetashev VI
    Ter Arkh; 1989; 61(3):94-7. PubMed ID: 2741128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid compositions of sera and synovial fluids from dog, human and horse: a comparison by 31P-NMR and MALDI-TOF MS.
    Fuchs B; Bondzio A; Wagner U; Schiller J
    J Anim Physiol Anim Nutr (Berl); 2009 Aug; 93(4):410-22. PubMed ID: 18484967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas.
    Kuliszkiewicz-Janus M; Baczyński S
    Magn Reson Med; 1996 Apr; 35(4):449-56. PubMed ID: 8992193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningioma phospholipid profiles measured by 31P nuclear magnetic resonance spectroscopy.
    Seijo L; Merchant TE; van der Ven LT; Minsky BD; Glonek T
    Lipids; 1994 May; 29(5):359-64. PubMed ID: 8015367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 31P NMR phospholipid characterization of intracranial tumors.
    Merchant TE; van der Ven LT; Minsky BD; Diamantis PM; Delapaz R; Galicich J; Glonek T
    Brain Res; 1994 Jun; 649(1-2):1-6. PubMed ID: 7953620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative analysis of the basic plasma phospholipids in anemia caused by malignant diseases].
    Jeannet M; Zahler P
    Schweiz Med Wochenschr; 1966 Aug; 96(33):1070-4. PubMed ID: 5997653
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
    Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status.
    Taylor LA; Arends J; Hodina AK; Unger C; Massing U
    Lipids Health Dis; 2007 Jul; 6():17. PubMed ID: 17623088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phospholipids in the blood serum of patients with ischemic heart disease at the stage of early rehabilitation at a sanatorium].
    Novgorodtseva TP; Endakova EA; Ivanov EM; Svetashev VI; Beliaeva NE
    Lab Delo; 1989; (1):15-8. PubMed ID: 2468016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [31P-MR spectroscopy of the brain in patients with anorexia nervosa: characteristic differences in the spectra between patients and healthy control subjects].
    Rzanny R; Freesmeyer D; Reichenbach JR; Mentzel HJ; Pfleiderer SO; Klemm S; Gerhard UJ; Blanz B; Kaiser WA
    Rofo; 2003 Jan; 175(1):75-82. PubMed ID: 12525985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.